Banka Bioloo Ltd
Utilities | Small Cap
Banka Bioloo Ltd, operating in the Construction & Engineering (Infrastructure) sector, exhibits a mixed financial performance. The company shows strong solvency due to its high equity ratio and lack of debt. Growth metrics are volatile, with high revenue and asset growth offset by negative operating profit and net income growth. Efficiency is hampered by low turnover ratios, though some ratios related to inventory and receivables appear strong. Coverage ratios are weak, indicating potential difficulties in meeting interest obligations. While profitability metrics are generally poor, the operating margin shows some strength. Overall, the company's financial health presents a complex picture with notable strengths in solvency and some growth aspects, contrasted by weaknesses in liquidity, efficiency, coverage, and profitability. External factors and market conditions could significantly influence future performance.
Latest Report
View AllThe Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.
Latest News
View AllThe Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.
- Valuation MetricsNeutral
- Market Metrics
- Stock Reports
- Stock News
- Growth Ratio2.80
- Financial Ratio2.00
- Profitability Ratio1.20
- Efficiency Ratio1.67
- Coverage Ratio1.00
- Solvency Ratio5.00
- Liquidity Ratio2.00
- Peer Assessment
- Management AssessmentWeak
- Risk AssessmentWeak
- 1 HourNeutral
- 2 HoursNeutral
- 4 HoursNeutral
- 1 DayNeutral
- 1 WeekNeutral
- 1 MonthNeutral
Banka Bioloo Ltd, operating in the Construction & Engineering (Infrastructure) sector, exhibits a mixed financial performance. The company shows strong solvency due to its high equity ratio and lack of debt. Growth metrics are volatile, with high revenue and asset growth offset by negative operating profit and net income growth. Efficiency is hampered by low turnover ratios, though some ratios related to inventory and receivables appear strong. Coverage ratios are weak, indicating potential difficulties in meeting interest obligations. While profitability metrics are generally poor, the operating margin shows some strength. Overall, the company's financial health presents a complex picture with notable strengths in solvency and some growth aspects, contrasted by weaknesses in liquidity, efficiency, coverage, and profitability. External factors and market conditions could significantly influence future performance.
Overall Valuation Score
P/E RATIO (TTM)
-15.84
Industry Median
16.74
Small Cap Median
17.70
P/E RATIO
-7.38
P/B RATIO
2.15
Industry Median
2.41
Small Cap Median
2.28
P/S RATIO
1.22
Industry Median
1.86
Small Cap Median
1.67
Others
PEG RATIO
0.00
EV/EBITDA RATIO
-23.55
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹60.5 as on Jun 15, 2026.
Unlock Live Chart
Please login to view interactive real-time technical charts powered by TradingView.
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
0.00
Today's Low
0.00
Today's High
The growth metrics are highly volatile, presenting a mixed outlook. While revenue and asset growth demonstrate positive momentum, the negative operating profit and net income growth raise concerns about sustainable profitability. The inconsistent growth patterns suggest potential challenges in managing costs or maintaining profitability as the company expands.
| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 27.22 | 9.29 | 18.06 | 8.36 | 5.37 |
| Operating Profit Growth Rate | 61.16 | 11.33 | -38.61 | -175 | -282.81 |
| Earnings Per Share (EPS) Growth | 34.11 | -18.47 | -125.64 | 1266.67 | -103.9 |
| Asset Growth Rate | 38.16 | 1.8 | 18.76 | 6.11 | 22.58 |
| Net Income Growth Rate | 41.36 | -18.33 | -126.38 | 1229.85 | -104.38 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
The financial ratios present a mixed view. While capital expenditures appear well-managed, other metrics such as adjusted earnings per share, book value per share, and dividend per share indicate potential areas of concern. The company's cash earnings per share show some strength, suggesting an ability to generate cash. Overall, the financial performance requires careful monitoring and strategic adjustments.
| Financial Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Adjusted Earnings Per Share (Adjusted EPS) | 2.88 | 2.35 | -0.62 | -8.17 | 0.36 |
| Cash Earnings Per Share (Cash EPS) | 3.75 | 3.72 | 1.41 | -5.85 | 2.93 |
| Book Value Per Share | 34.73 | 37.13 | 36.78 | 28.91 | 36.28 |
| Dividend Per Share (DPS) | 0 | 0 | 0 | 0 | 0 |
| Capital Expenditures (CapEx) | 3.2 | 6.4 | 10 | 4.4 | 6 |
Adjusted Earnings Per Share (Adjusted EPS)
Cash Earnings Per Share (Cash EPS)
Book Value Per Share
Dividend Per Share (DPS)
Capital Expenditures (CapEx)
The profitability metrics paint a concerning picture, with several ratios indicating poor performance. While the operating margin shows some strength, the gross profit margin, return on capital employed, return on equity, return on assets, and net margin all suggest challenges in generating profits. The company needs to implement strategies to improve its cost management, pricing, and asset utilization.
| Profitability Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Profit Margin | 11.92 | 11.12 | 3.22 | -9.93 | 4.22 |
| Return on Capital Employed (ROCE) | 10.44 | 9.61 | 3.43 | -7.61 | 4.98 |
| Return on Equity (ROE) | 8.29 | 6.33 | -1.69 | -28.28 | 0.99 |
| Return on Assets (ROA) | 8.68 | 9.49 | 4.91 | -3.47 | 5.17 |
| Operating Margin | 14.35 | 14.62 | 7.6 | -5.26 | 9.13 |
| Net Margin | 8.03 | 6 | -1.34 | -16.45 | 0.68 |
Gross Profit Margin
Return on Capital Employed (ROCE)
Return on Equity (ROE)
Return on Assets (ROA)
Operating Margin
Net Margin
The efficiency ratios present a mixed picture. While some ratios related to inventory and receivable management appear strong, the overall efficiency is hampered by low turnover ratios. This could indicate challenges in effectively utilizing assets to generate revenue. The company might need to assess its operational processes to enhance efficiency and optimize asset utilization.
| Efficiency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Fixed Asset Turnover Ratio | 5.72 | 3.97 | 3.25 | 3.42 | 2.06 |
| Inventory Turnover Ratio | 4.16 | 4.4 | 5.7 | 8.46 | 9.16 |
| Receivables Turnover Ratio | 2.42 | 1.96 | 2.18 | 2.13 | 2 |
| Days Sales in Inventory Ratio | 87.74 | 82.95 | 64.04 | 43.14 | 39.85 |
| Receivable Days | 150.83 | 186.22 | 167.43 | 171.36 | 182.5 |
| Capital Turnover Ratio | 0.82 | 0.91 | 0.97 | 1.24 | 1.06 |
Fixed Asset Turnover Ratio
Inventory Turnover Ratio
Receivables Turnover Ratio
Days Sales in Inventory Ratio
Receivable Days
Capital Turnover Ratio
Coverage ratios are weak, signaling potential difficulties in meeting financial obligations, particularly interest payments. This could stem from low earnings or high debt levels. The company may face challenges in servicing its debt if earnings decline or interest rates rise. Prudent financial management and strategies to improve earnings are crucial.
| Coverage Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Interest Coverage Ratio | 2.85 | 3.03 | 0.79 | -1.41 | 0.93 |
| Equity Dividend Coverage Ratio |
Interest Coverage Ratio
Equity Dividend Coverage Ratio
The company demonstrates strong solvency, with a financial structure heavily reliant on equity and minimal debt. This indicates a low risk of financial distress and a high degree of financial stability. The company's ability to fund its operations and growth through equity provides a solid foundation, reducing vulnerability to economic downturns or changes in interest rates.
| Solvency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debt Ratio | 0.2 | 0.14 | 0.23 | 0.28 | 0.27 |
| Debt to Equity Ratio | 0.25 | 0.16 | 0.3 | 0.39 | 0.37 |
| Equity Ratio | 0.8 | 0.86 | 0.77 | 0.72 | 0.73 |
| Debt To Asset Ratio | 0.15 | 0.1 | 0.16 | 0.15 | 0.14 |
Debt Ratio
Debt to Equity Ratio
Equity Ratio
Debt To Asset Ratio
The liquidity position is weak, indicating potential difficulties in meeting short-term obligations. The ratios suggest that the company may struggle to convert its current assets into cash quickly. This could be due to challenges in managing working capital or holding illiquid assets. While the company might be able to operate in the short term, sustained low liquidity could pose risks to its financial stability.
| Liquidity Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Current Ratio | 3.23 | 2.76 | 2.16 | 1.52 | 1.55 |
| Quick Ratio | 2.74 | 2.29 | 1.84 | 1.37 | 1.42 |
| Cash Ratio | 0.25 | 0.14 | 0.1 | 0.12 | 0.24 |
| Operating Cash Flow Ratio | -0.03 | 0.4 | 0.11 | 0.02 | 0.02 |
Current Ratio
Quick Ratio
Cash Ratio
Operating Cash Flow Ratio
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | K2 Infragen Ltd | 6.89 | 6.56 | Neutral | 23.00 | 10.56 | 13.00 |
| 2 | Konstelec Engineers Ltd | 4.97 | 15.62 | Highly Undervalued | 19.00 | 4.96 | 7.00 |
| 3 | Banka Bioloo Ltd | 4.77 | -7.38 | Neutral | 5.21 | 0.35 | 0.39 |
| 4 | ARSS Infrastructure Projects Ltd | 4.67 | 0.00 | Highly Undervalued | -13.00 | -4.18 | -8.00 |
| 5 | Teamo Productions HQ Ltd | 3.71 | -9.80 | Neutral | -0.07 | 0.00 | -1.04 |
The management effectiveness of Banka Bioloo Ltd is concerning. Despite sales growth, the company's profitability has declined significantly, with a negative net profit. Decreasing promoter holding and a negative ROCE further highlight management challenges. Inefficient working capital management also contributes to a negative assessment.
| Category | Metric | Value | Assessment |
|---|---|---|---|
| PROS | Sales Growth | 8.34% | Sales have shown growth in the last few years. |
| CONS | Profitability | -8.91 Cr. | Net profit has declined significantly and is currently negative. |
| Promoter Holding | 52.44% | Promoter holding has decreased over the years. | |
| ROCE | -7.64% | Return on Capital Employed has turned negative. |
Financial Performance & Growth
Banka Bioloo's financial performance shows a concerning trend. While Sales Growth % was 8.34% in Mar 2025, the company's profitability has deteriorated significantly, with a Net Profit of -8.91 Cr in Mar 2025. OPM % also declined to -5.30% in Mar 2025. The inconsistency in earnings and negative profitability raise concerns about the company's financial stability. The compounded profit growth is also negative, further highlighting the challenges in maintaining profitability.
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Sales Growth (%) | -36.36% | 27.22% | 9.29% | 18.06% | 8.34% |
Capital Efficiency & Returns
The capital efficiency and returns for Banka Bioloo are weak. The ROCE % has declined and turned negative at -7.64% in Mar 2025, indicating that capital is not being used productively. ROE is also negative, suggesting poor returns on shareholder funds. The Cash Conversion Cycle is high, indicating inefficient working capital management.
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| ROCE (%) | 8.33% | 10.44% | 9.61% | 3.43% | -7.64% |
Financial Health & Prudence
Banka Bioloo's financial health shows signs of concern. The company's borrowings have increased to 34.73 Cr in Mar 2025. The Interest Coverage Ratio is decreasing due to declining profitability. The company does not have a dividend payout, which reflects its current financial constraints. The increasing debt and decreasing profitability pose risks to the company's financial stability.
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Borrowings (Cr) | 11.69 | 18.50 | 16.71 | 25.91 | 34.73 |
Shareholding & Ownership Structure
The shareholding pattern indicates a decrease in promoter holding over the years. The promoter holding has decreased from 58.57% in Mar 2022 to 52.44% in Mar 2025. The FII holding is negligible. The decreasing promoter holding may raise concerns about the long-term commitment of the promoters.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Promoter Holding (%) | 58.57% | 55.17% | 52.72% | 52.44% |
Banka Bioloo faces significant risks due to its negative profitability, increasing debt, and inefficient working capital management. The declining ROCE and ROE indicate poor capital allocation and returns on shareholder funds. Decreasing promoter holding and absence of institutional investment further exacerbate these risks, resulting in a high-risk assessment.
Segment performance volatility
The quarterly results show significant volatility in segment performance. The OPM % fluctuates widely, ranging from -36.10% to 20.73%. Net Profit also shows substantial variation, with periods of profit and significant losses. This volatility indicates instability in the company's operations and financial performance.
Foreign exchange or interest rate exposure
The company's increasing borrowings expose it to interest rate risk. The interest expenses have been increasing, impacting the profitability.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Interest (Cr) | 1.79 | 1.79 | 2.66 | 3.76 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Hour Timeframe
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 2 Hours Timeframe
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 4 Hours Timeframe
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Day Timeframe
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Week Timeframe
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Month Timeframe